Comments
Loading...

Inspire Medical Systems Analyst Ratings

INSPNYSE
Logo brought to you by Benzinga Data
$140.28
-2.87-2.00%
At close: -
$140.28
0.000.00%
After Hours: 4:00 PM EDT
Consensus Rating1
Overweight
Highest Price Target1
$350.00
Lowest Price Target1
$174.00
Consensus Price Target1
$244.83

Inspire Medical Systems Analyst Ratings and Price Targets | NYSE:INSP | Benzinga

Inspire Medical Systems Inc has a consensus price target of $244.83 based on the ratings of 19 analysts. The high is $350 issued by Lake Street on August 2, 2023. The low is $174 issued by Wells Fargo on May 6, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, JP Morgan, and Wells Fargo on May 6, 2025, respectively. With an average price target of $189.67 between Morgan Stanley, JP Morgan, and Wells Fargo, there's an implied 35.21% upside for Inspire Medical Systems Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jan
5
1
Feb
2
Apr
3
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Morgan Stanley
JP Morgan
Wells Fargo
Baird
Stifel

1calculated from analyst ratings

Analyst Ratings for Inspire Medical Systems

Buy NowGet Alert
05/06/2025Buy Now42.57%Morgan Stanley
Kallum Titchmarsh25%
$220 → $200MaintainsOverweightGet Alert
05/06/2025Buy Now39.01%JP Morgan
Robbie Marcus67%
$235 → $195MaintainsOverweightGet Alert
05/06/2025Buy Now24.04%Wells Fargo
Larry Biegelsen66%
$195 → $174MaintainsEqual-WeightGet Alert
05/06/2025Buy Now68.23%Baird
Mike Polark56%
$230 → $236MaintainsOutperformGet Alert
04/21/2025Buy Now24.75%Stifel
Jonathan Block72%
$190 → $175MaintainsHoldGet Alert
04/21/2025Buy Now53.98%Keybanc
Tim Rezvan49%
$234 → $216MaintainsOverweightGet Alert
04/15/2025Buy Now53.26%RBC Capital
Shagun Singh56%
$260 → $215MaintainsOutperformGet Alert
02/11/2025Buy Now67.52%Truist Securities
Richard Newitter74%
$250 → $235MaintainsBuyGet Alert
02/11/2025Buy Now85.34%RBC Capital
Shagun Singh56%
$260 → $260ReiteratesOutperform → OutperformGet Alert
02/11/2025Buy Now76.79%Baird
Mike Polark56%
$252 → $248MaintainsOutperformGet Alert
02/11/2025Buy Now39.01%Wells Fargo
Larry Biegelsen66%
$198 → $195MaintainsEqual-WeightGet Alert
02/11/2025Buy Now56.83%Morgan Stanley
Kallum Titchmarsh25%
$230 → $220MaintainsOverweightGet Alert
02/10/2025Buy Now66.1%Piper Sandler
Adam Maeder62%
$260 → $233MaintainsOverweightGet Alert
01/24/2025Buy Now66.81%Keybanc
Brett Fishbin50%
$236 → $234ReiteratesOverweight → OverweightGet Alert
01/21/2025Buy Now35.44%Stifel
Jonathan Block72%
$200 → $190MaintainsHoldGet Alert
11/20/2024Buy Now81.78%B of A Securities
Bob Hopkins45%
$220 → $255UpgradeNeutral → BuyGet Alert
11/05/2024Buy Now85.34%RBC Capital
Shagun Singh56%
$260 → $260ReiteratesOutperform → OutperformGet Alert
11/05/2024Buy Now85.34%Piper Sandler
Adam Maeder62%
$255 → $260ReiteratesOverweight → OverweightGet Alert
11/05/2024Buy Now42.57%Stifel
Jonathan Block72%
$170 → $200ReiteratesHold → HoldGet Alert
11/05/2024Buy Now41.15%Wells Fargo
Larry Biegelsen66%
$187 → $198MaintainsEqual-WeightGet Alert
11/05/2024Buy Now79.64%Baird
Mike Polark56%
$240 → $252MaintainsOutperformGet Alert
09/30/2024Buy Now71.09%Truist Securities
Richard Newitter74%
$217 → $240ReiteratesBuy → BuyGet Alert
09/10/2024Buy Now40.43%Leerink Partners
Mike Kratky65%
$167 → $197MaintainsMarket PerformGet Alert
08/07/2024Buy Now68.23%Keybanc
Brett Fishbin50%
$278 → $236MaintainsOverweightGet Alert
08/07/2024Buy Now85.34%RBC Capital
Shagun Singh56%
$260 → $260ReiteratesOutperform → OutperformGet Alert
08/07/2024Buy Now42.57%Baird
Mike Polark56%
$220 → $200MaintainsOutperformGet Alert
07/16/2024Buy Now54.69%Truist Securities
Richard Newitter74%
$280 → $217MaintainsBuyGet Alert
07/15/2024Buy Now49.7%Morgan Stanley
Kallum Titchmarsh25%
$250 → $210MaintainsOverweightGet Alert
06/24/2024Buy Now21.19%Stifel
Jonathan Block72%
$210 → $170MaintainsHoldGet Alert
06/03/2024Buy Now31.88%B of A Securities
Bob Hopkins45%
$225 → $185MaintainsNeutralGet Alert
05/08/2024Buy Now81.78%Piper Sandler
Adam Maeder62%
$250 → $255MaintainsOverweightGet Alert
04/19/2024Buy Now103.17%RBC Capital
Shagun Singh56%
→ $285Initiates → OutperformGet Alert
03/27/2024Buy Now78.21%Mizuho
Anthony Petrone63%
$250 → $250MaintainsBuyGet Alert
03/20/2024Buy Now99.6%Truist Securities
Richard Newitter74%
→ $280ReiteratesBuy → BuyGet Alert
03/19/2024Buy Now78.21%Morgan Stanley
Kallum Titchmarsh25%
→ $250Initiates → OverweightGet Alert
02/07/2024Buy Now99.6%Truist Securities
Richard Newitter74%
$265 → $280MaintainsBuyGet Alert
02/07/2024Buy Now78.21%Mizuho
Anthony Petrone63%
$225 → $250MaintainsBuyGet Alert
02/06/2024Buy Now98.18%Keybanc
Brett Fishbin50%
→ $278Initiates → OverweightGet Alert
01/19/2024Buy Now74.65%Jefferies → $245Initiates → BuyGet Alert
01/02/2024Buy Now49.7%Stifel
Jonathan Block72%
→ $210DowngradeBuy → HoldGet Alert
12/22/2023Buy Now85.34%Truist Securities
Richard Newitter74%
$240 → $260MaintainsBuyGet Alert
12/13/2023Buy Now33.3%Wells Fargo
Larry Biegelsen66%
→ $187DowngradeOverweight → Equal-WeightGet Alert
11/08/2023Buy Now49.7%Stifel
Jonathan Block72%
$250 → $210MaintainsBuyGet Alert
11/08/2023Buy Now53.26%Mizuho
Anthony Petrone63%
$300 → $215MaintainsBuyGet Alert
11/08/2023Buy Now71.09%Truist Securities
Richard Newitter74%
$260 → $240MaintainsBuyGet Alert
11/08/2023Buy Now74.65%Wells Fargo
Larry Biegelsen66%
$330 → $245MaintainsOverweightGet Alert
11/07/2023Buy Now78.21%Stifel
Jonathan Block72%
$350 → $250MaintainsBuyGet Alert
10/17/2023Buy Now29.03%JP Morgan
Robbie Marcus67%
$340 → $181MaintainsOverweightGet Alert
10/16/2023Buy Now13.34%Leerink Partners
Mike Kratky65%
→ $159Initiates → Market PerformGet Alert
10/02/2023Buy Now142.37%Truist Securities
Richard Newitter74%
→ $340ReiteratesBuy → BuyGet Alert
09/06/2023Buy Now129.54%UBS
Danielle Antalffy60%
$405 → $322MaintainsBuyGet Alert
08/24/2023Buy Now142.37%Truist Securities
Richard Newitter74%
$363 → $340MaintainsBuyGet Alert
08/02/2023Buy Now142.37%JP Morgan
Robbie Marcus67%
$300 → $340MaintainsOverweightGet Alert
08/02/2023Buy Now149.5%Lake Street
Frank Takkinen34%
$305 → $350MaintainsBuyGet Alert
08/02/2023Buy Now158.77%Truist Securities
Richard Newitter74%
$380 → $363MaintainsBuyGet Alert
08/02/2023Buy Now135.24%Wells Fargo
Larry Biegelsen66%
$315 → $330MaintainsOverweightGet Alert
07/19/2023Buy Now170.89%Truist Securities
Richard Newitter74%
$360 → $380MaintainsBuyGet Alert
07/19/2023Buy Now164.47%Baird
Mike Polark56%
→ $371Initiates → OutperformGet Alert
07/13/2023Buy Now149.5%Stifel
Jonathan Block72%
$300 → $350MaintainsBuyGet Alert
07/05/2023Buy Now153.07%B of A Securities
Bob Hopkins45%
$310 → $355MaintainsBuyGet Alert
06/12/2023Buy Now113.86%Mizuho
Anthony Petrone63%
→ $300ReiteratesBuy → BuyGet Alert
06/08/2023Buy Now142.37%Piper Sandler
Adam Mizrahi44%
$315 → $340MaintainsOverweightGet Alert
06/08/2023Buy Now138.81%Keybanc
Matthew Mishan53%
$321 → $335MaintainsOverweightGet Alert
05/18/2023Buy Now156.63%Piper Sandler
Adam Mizrahi44%
$335 → $360MaintainsOverweightGet Alert
05/03/2023Buy Now116.71%UBS
Danielle Antalffy60%
$300 → $304MaintainsBuyGet Alert
05/03/2023Buy Now124.55%Piper Sandler
Adam Mizrahi44%
$305 → $315MaintainsOverweightGet Alert
05/03/2023Buy Now128.83%Keybanc
Matthew Mishan53%
$303 → $321MaintainsOverweightGet Alert
04/14/2023Buy Now113.86%Mizuho
Anthony Petrone63%
→ $300Initiates → BuyGet Alert
04/13/2023Buy Now113.86%Mizuho
Anthony Petrone63%
→ $300Initiates → BuyGet Alert
04/11/2023Buy Now113.86%Stifel
Jonathan Block72%
$290 → $300MaintainsBuyGet Alert
03/29/2023Buy Now113.86%UBS
Danielle Antalffy60%
→ $300Initiates → BuyGet Alert
02/08/2023Buy Now135.24%Truist Securities
Richard Newitter74%
$310 → $330MaintainsBuyGet Alert
02/08/2023Buy Now113.86%JP Morgan
Robbie Marcus67%
$271 → $300MaintainsOverweightGet Alert
02/08/2023Buy Now117.42%Piper Sandler
Adam Maeder62%
$300 → $305MaintainsOverweightGet Alert
01/31/2023Buy Now120.99%Truist Securities
Richard Newitter74%
$308 → $310MaintainsBuyGet Alert
01/26/2023Buy Now113.86%Piper Sandler
Adam Maeder62%
$285 → $300MaintainsOverweightGet Alert
01/13/2023Buy Now116%Keybanc
Matthew Mishan53%
$287 → $303MaintainsOverweightGet Alert
12/20/2022Buy Now119.56%Truist Securities
Richard Newitter74%
$270 → $308MaintainsBuyGet Alert
12/13/2022Buy NowGoldman Sachs
Amit Hazan56%
UpgradeNeutral → BuyGet Alert
12/13/2022Buy Now104.59%Keybanc
Matthew Mishan53%
→ $287Initiates → OverweightGet Alert
10/17/2022Buy Now71.09%Truist Securities
Richard Newitter74%
$280 → $240MaintainsBuyGet Alert
08/03/2022Buy Now103.17%Piper Sandler
Adam Maeder62%
$310 → $285MaintainsOverweightGet Alert
06/10/2022Buy Now78.21%Truist Securities
Richard Newitter74%
$296 → $250MaintainsBuyGet Alert

FAQ

Q

What is the target price for Inspire Medical Systems (INSP) stock?

A

The latest price target for Inspire Medical Systems (NYSE:INSP) was reported by Morgan Stanley on May 6, 2025. The analyst firm set a price target for $200.00 expecting INSP to rise to within 12 months (a possible 42.57% upside). 30 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Inspire Medical Systems (INSP)?

A

The latest analyst rating for Inspire Medical Systems (NYSE:INSP) was provided by Morgan Stanley, and Inspire Medical Systems maintained their overweight rating.

Q

When was the last upgrade for Inspire Medical Systems (INSP)?

A

The last upgrade for Inspire Medical Systems Inc happened on November 20, 2024 when B of A Securities raised their price target to $255. B of A Securities previously had a neutral for Inspire Medical Systems Inc.

Q

When was the last downgrade for Inspire Medical Systems (INSP)?

A

The last downgrade for Inspire Medical Systems Inc happened on January 2, 2024 when Stifel changed their price target from N/A to $210 for Inspire Medical Systems Inc.

Q

When is the next analyst rating going to be posted or updated for Inspire Medical Systems (INSP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inspire Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inspire Medical Systems was filed on May 6, 2025 so you should expect the next rating to be made available sometime around May 6, 2026.

Q

Is the Analyst Rating Inspire Medical Systems (INSP) correct?

A

While ratings are subjective and will change, the latest Inspire Medical Systems (INSP) rating was a maintained with a price target of $220.00 to $200.00. The current price Inspire Medical Systems (INSP) is trading at is $140.28, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch